NIH launches clinical trial of universal influenza vaccine candidate
Nanoparticle vaccine developed by NIAID scientists A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide...
















